Bone marrow biopsy (BM) morphology in patients with chronic myeloid leukemia (CML) treated with STI571

被引：0
|
作者：
Chiu, A
Silver, R
Rosamillia, M
Chadburn, A
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY USA
[2] Novartis Pharmaceut AG, Basel, Switzerland
来源：
MODERN PATHOLOGY | 2001年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
934
引用
收藏
页码：159A / 159A
页数：1
相关论文
共 50 条
  • [21] Imatinib mesylate (STI571) for myeloid malignancies other than CML
    Krystal, GW
    LEUKEMIA RESEARCH, 2004, 28 : S53 - S59
  • [22] Effects of the tyrosine kinase inhibitor Imatinib mesylate (STI571) on bone marrow features in patients with chronic myelogenous leukemia
    Thiele, J
    Kvasnicka, HM
    Schmitt-Graeff, A
    Kriener, S
    Engels, K
    Staib, P
    Griesshammer, M
    Waller, CF
    Ottmann, OG
    Hansmann, M
    HISTOLOGY AND HISTOPATHOLOGY, 2004, 19 (04) : 1277 - 1288
  • [23] Immunomodulatory effects of STI571 in chronic myeloid leukaemia
    Bund, D.
    Yang, T.
    Buhmann, R.
    Kolb, H. -J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S317 - S317
  • [24] Morphologic Changes in the Bone Marrow in Patients of Chronic Myeloid Leukemia (CML) Treated with ImatinibMesylate
    Srinivas, B. H.
    Paul, T. Roshni
    Uppin, Shantveer G.
    Uppin, Megha S.
    Jacob, Rachel T.
    Raghunadharao, D.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2012, 28 (03) : 162 - 169
  • [25] Morphologic Changes in the Bone Marrow in Patients of Chronic Myeloid Leukemia (CML) Treated with ImatinibMesylate
    B. H. Srinivas
    T. Roshni Paul
    Shantveer G. Uppin
    Megha S. Uppin
    Rachel T. Jacob
    D. Raghunadharao
    Indian Journal of Hematology and Blood Transfusion, 2012, 28 : 162 - 169
  • [26] Alpha 1 acid glycoprotein (AGP) binds to STI571 and substantially alters its pharmacokinetics in chronic myeloid leukemia (CML) patients.
    Gambacorti-Passeri, C
    Zucchetti, M
    Frapolli, R
    Russo, D
    Rossi, F
    Pogliani, E
    Corneo, G
    Tornaghi, L
    Alberti, D
    D'Incalci, M
    BLOOD, 2001, 98 (11) : 309A - 309A
  • [27] Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia
    Brouard, MC
    Prins, C
    Mach-Pascual, S
    Saurat, JH
    DERMATOLOGY, 2001, 203 (01) : 57 - 59
  • [28] Accelerated phase (AP) and blast phase (BP) chronic myelogenous leukemia (CML) treated with STI-571 (Gleevec): Peripheral blood (PB) and bone marrow (BM) findings
    Frater, JL
    Tallman, MS
    Variakojis, D
    Boehlke, L
    Peterson, LC
    LABORATORY INVESTIGATION, 2002, 82 (01) : 241A - 241A
  • [29] Accelerated phase (AP) and blast phase (BP) chronic myelogenous leukemia (CML) treated with STI-571 (Gleevec): Peripheral blood (PB) and bone marrow (BM) findings
    Frater, JL
    Tallman, MS
    Variakojis, D
    Boehlke, L
    Peterson, LC
    MODERN PATHOLOGY, 2002, 15 (01) : 241A - 241A
  • [30] Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukaemia
    McNamara, C
    Grigg, A
    Szer, J
    Roberts, A
    Campbell, L
    Hoyt, R
    Lynch, K
    Juneja, S
    CLINICAL AND LABORATORY HAEMATOLOGY, 2003, 25 (02): : 119 - 125
12345